Aqua Bio Technology ASA - Key information relating to the Subsequent Offering

11 Mar 2025 23:47 CET

11.3.2025 23:47:17 CET | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 11 March
2025 concerning the successful placement of the conditional private placement
with total gross proceeds of approximately NOK 24.2 million, and a contemplated
subsequent offering (the "Subsequent Offering").



Key information for the Subsequent Offering is set out below:



Date on which the terms of the Subsequent 11 March 2025

Offering was announced:



Last day including right: 11 March 2025



First day excluding right: 12 March 2025



Record date: 13 March 2025



EGM date: On or about 8 April 2025 (to be summoned)



Maximum number of new shares: 20,000,000



Subscription price: NOK 0.50



Shall the rights be listed No





The issuance of new shares in the Subsequent Offering will be subject to
approval of the pertaining share capital increase by the EGM to be held on or
about 4 April 2025. The Board will assess the appropriate size of the Subsequent
Offering and announce the final number of Offer Shares to be offered shortly
prior to launch of the Subsequent Offering. The Subsequent Offering is expected
to be carried out during the notice period for the EGM, with a one-week
subscription period, expected to expire at least three days prior to the date of
the EGM.



The new shares in the Subsequent Offering will initially be delivered on a
separate ISIN as the listing of such new shares requires the preparation and
publication of a prospectus approved by the Norwegian Financial Supervisory
Authority.



This information is published in accordance with the requirements of the
Continuing Obligations in Euronext Rule Book II.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78,
fredrik.henriksen@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood.
The group has distribution towards B2C, B2B, B2B2, and freight, customs, and
logistics services. The group also develops sustainable biotechnology for use in
skincare products. Aqua Bio Technology is listed on the Euronext Expand market
of the Oslo Stock Exchange.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18452470/5768/Download%20announce
ment%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

640972_Download announcement as PDF.pdf